Pacer Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$31.1M Sell
127,383
-68,084
-35% -$15.9M 0.09% 238
2025
Q4
$40.5M Sell
195,467
-299,694
-61% -$59.3M 0.1% 215
2025
Q3
$91.8M Sell
495,161
-2,632,092
-84% -$451M 0.23% 88
2025
Q2
$478M Buy
3,127,253
+97,169
+3% +$14.9M 1.19% 12
2025
Q1
$503M Buy
3,030,084
+2,825,626
+1,382% +$442M 1.18% 14
2024
Q4
$29.6M Sell
204,458
-61,230
-23% -$9.49M 0.06% 271
2024
Q3
$43.1M Buy
265,688
+25,083
+10% +$4M 0.09% 229
2024
Q2
$35.2M Buy
240,605
+31,908
+15% +$4.75M 0.08% 247
2024
Q1
$33M Buy
208,697
+25,034
+14% +$3.98M 0.08% 253
2023
Q4
$28.8M Buy
183,663
+26,461
+17% +$4.06M 0.08% 244
2023
Q3
$24.5M Sell
157,202
-7,990
-5% -$1.32M 0.09% 215
2023
Q2
$27.3M Buy
165,192
+3,891
+2% +$628K 0.11% 186
2023
Q1
$25M Buy
161,301
+69,842
+76% +$11.3M 0.11% 195
2022
Q4
$16.2M Buy
91,459
+81,343
+804% +$14M 0.08% 194
2022
Q3
$1.65M Sell
10,116
-56,430
-85% -$9.55M 0.01% 446
2022
Q2
$11.8M Sell
66,546
-70,833
-52% -$12.6M 0.09% 198
2022
Q1
$24.3M Sell
137,379
-2,225
-2% -$379K 0.2% 97
2021
Q4
$23.9M Sell
139,604
-20,551
-13% -$3.36M 0.24% 59
2021
Q3
$25.9M Buy
160,155
+9,365
+6% +$1.6M 0.33% 37
2021
Q2
$24.8M Buy
150,790
+4,828
+3% +$799K 0.36% 32
2021
Q1
$24M Sell
145,962
-12,863
-8% -$2.08M 0.42% 28
2020
Q4
$25M Sell
158,825
-33,871
-18% -$5M 0.47% 26
2020
Q3
$28.7M Sell
192,696
-32,251
-14% -$4.77M 0.61% 25
2020
Q2
$31.6M Buy
+224,947
New +$32.8M 0.64% 24
2020
Q1
Sell
-301,184
Closed -$43.9M 894
2019
Q4
$43.9M Buy
301,184
+15,698
+5% +$2.13M 1.98% 2
2019
Q3
$36.9M Buy
285,486
+30,395
+12% +$4M 0.83% 11
2019
Q2
$35.5M Buy
255,091
+15,612
+7% +$2.16M 0.87% 9
2019
Q1
$33.5M Buy
239,479
+239,316
+146,820% +$32.1M 0.93% 10
2018
Q4
$21K Sell
163
-143,197
-100% -$20M ﹤0.01% 371
2018
Q3
$19.8M Buy
143,360
+17,736
+14% +$2.36M 0.75% 12
2018
Q2
$15.2M Buy
125,624
+23,172
+23% +$2.89M 0.69% 12
2018
Q1
$13.1M Buy
102,452
+11,499
+13% +$1.55M 0.73% 17
2017
Q4
$12.7M Buy
90,953
+20,106
+28% +$2.8M 0.89% 11
2017
Q3
$9.21M Buy
70,847
+6,833
+11% +$906K 0.82% 10
2017
Q2
$8.47M Buy
64,014
+4,307
+7% +$549K 0.84% 7
2017
Q1
$7.44M Buy
59,707
+2,696
+5% +$322K 0.91% 7
2016
Q4
$6.57M Buy
57,011
+763
+1% +$88.1K 0.94% 9
2016
Q3
$6.64M Sell
56,248
-1,698
-3% -$206K 1.01% 7
2016
Q2
$7.03M Buy
57,946
+6,218
+12% +$707K 1.11% 7
2016
Q1
$5.6M Buy
51,728
+557
+1% +$57.7K 1.27% 9
2015
Q4
$5.26M Buy
51,171
+48,914
+2,167% +$4.92M 1.24% 9
2015
Q3
$211K Hold
2,257
0.51% 85
2015
Q2
$220K Hold
2,257
0.46% 96
2015
Q1
$227K Buy
+2,257
New +$230K 0.47% 84
2013
Q4
$1.65M Buy
+15,756
New +$1.45M 0.4% 59

Other funds holding JNJ

Pacer Advisors's JNJ Position: Q1 2026 in Review

Pacer Advisors reduced its Johnson & Johnson (JNJ) stake by 35% in Q1 2026, selling an estimated $15.9M and leaving 127,383 shares worth $31.1M. The position accounts for 0.09% of the portfolio, ranked #238.

Pacer Advisors first reported a position in JNJ in Q4 2013 and has held it in 45 quarters since. The position peaked at $503M in Q1 2025. 4,615 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Pacer Advisors held 127,383 shares of Johnson & Johnson worth $31.1M as of Q1 2026.
  • Pacer Advisors sold 68,084 Johnson & Johnson shares in Q1 2026, an estimated $15.9M.
  • Johnson & Johnson made up 0.09% of Pacer Advisors's portfolio in Q1 2026, its #238 holding.
  • Pacer Advisors first reported a position in Johnson & Johnson in Q4 2013 and has held it in 45 quarters since.
  • Pacer Advisors's Johnson & Johnson position peaked at $503M in Q1 2025.
  • 4,615 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Pacer Advisors's 13F filing for Q1 2026, filed 6 May 2026.